determin
rate
symptomat
asymptomat
infect
among
ambulatori
adult
collect
nasopharyng
swab
specimen
demograph
characterist
survey
inform
adult
visitor
new
york
citi
tourist
attract
apriljuli
multiplex
polymeras
chain
reaction
analysi
use
identifi
specimen
posit
common
respiratori
virus
total
sampl
test
posit
respiratori
virus
among
posit
sampl
contain
rhinoviru
contain
coronaviru
influenza
viru
respiratori
syncyti
viru
parainfluenza
viru
also
detect
depend
symptomatolog
definit
posit
sampl
asymptomat
find
indic
signific
level
asymptomat
respiratori
viral
shed
exist
summer
among
ambulatori
adult
popul
much
surveil
respiratori
viru
infect
human
conduct
network
clinic
hospit
perform
patient
servic
specif
patient
present
influenzalik
ill
anoth
nonspecif
ill
record
medic
clinic
emerg
depart
number
report
counti
state
health
agenc
specimen
also
obtain
individu
present
influenzalik
ill
similar
symptom
test
presenc
respiratori
viru
use
rapid
diagnost
laboratori
assay
data
provid
estim
respiratori
viru
infect
rate
among
seek
medic
attent
howev
surveil
system
owe
passiv
form
captur
infect
rate
among
popul
individu
seek
medic
attent
latter
unrepres
individualsperson
seek
medic
attentionconstitut
gener
undocu
popul
experienc
asymptomat
symptomat
respiratori
viru
infect
person
may
wholli
unawar
infect
experi
mild
symptom
becom
iller
choos
seek
medic
attent
explor
respiratori
viru
infect
rate
segment
popul
conveni
survey
sampl
studi
adult
visitor
new
york
citi
tourist
attract
spring
summer
solicit
particip
among
visitor
new
york
citi
tourist
attract
juli
locat
collect
point
tourist
local
provid
crosssect
potenti
particip
broadli
repres
local
visit
popul
new
york
citi
activ
includ
particip
solicit
consent
survey
sampl
respiratori
virus
perform
weekend
attract
adult
age
year
interest
particip
provid
detail
studi
descript
consent
form
columbia
univers
medic
center
institut
review
board
irb
approv
american
museum
natur
histori
irb
approv
consent
adult
administ
baselin
survey
nasopharyng
swab
sampl
one
nostril
collect
particip
ask
provid
inform
age
race
sex
recent
travel
preexist
medic
condit
includ
season
allergi
well
rate
current
symptom
commonli
relat
respiratori
tract
infect
see
supplementari
materi
full
survey
per
common
cold
questionnair
symptomsfev
chill
muscl
pain
wateri
eye
runni
nose
sneez
sore
throat
cough
chest
painwer
record
likert
scale
ie
none
mild
moder
sever
individu
symptom
quantifi
basi
design
ie
none
mild
moder
sever
total
symptom
score
talli
sum
symptom
valu
rang
nasopharyng
sampl
collect
use
minitip
flock
swab
vwr
catalog
copan
diagnost
sampl
store
jointli
ml
dnarna
shield
product
zymo
research
day
aliquot
two
cryovial
store
nucleic
acid
extract
thaw
sampl
use
easymag
nuclisen
autom
system
biomerieux
revers
transcriptionpolymeras
chain
reaction
analysi
amplif
perform
use
veriti
thermal
cycler
appli
biosystem
per
genmark
packag
instruct
sampl
subject
genmark
rvp
exonucleas
polymeras
chain
reaction
program
transfer
genmark
rvp
cartridg
load
esensor
measur
signal
intens
per
manufactur
protocol
genmark
esensor
rvp
system
separ
detect
influenza
viru
subtyp
influenza
influenza
pandem
influenza
influenza
b
viru
respiratori
syncyti
viru
b
parainfluenza
viru
human
metapneumoviru
human
rhinoviru
hrv
adenoviru
c
coronaviru
cov
cov
cov
cov
esensor
system
measur
electr
signal
intens
nanoamp
per
millimet
squar
per
manufactur
specif
sampl
posit
particular
viru
identifi
intens
namm
test
sensit
find
standard
definit
symptomat
infect
exist
use
multipl
definit
delin
symptomat
asymptomat
particip
first
symptomat
classif
definit
requir
selfreport
symptom
least
moder
sever
definit
relax
standard
requir
symptom
moder
sever
fever
cough
sore
throat
symptom
use
diagnos
influenzalik
ill
use
delin
remain
symptomat
definit
definit
symptomat
particip
selfreport
fever
cough
sore
throat
moder
sever
mild
wors
fever
mild
wors
cough
sore
throat
need
symptomat
accord
definit
definit
requir
mild
wors
fever
moder
wors
cough
sore
throat
research
protocol
exploratori
hypothes
shed
particip
would
like
symptomat
travel
age
would
associ
shed
statist
differ
symptom
score
among
categor
group
eg
age
race
assess
use
analysi
varianc
anova
tukey
test
wherea
differ
across
pair
categor
variabl
eg
symptomat
posit
infect
assess
use
analysi
fisher
exact
test
associ
signal
intens
among
posit
sampl
posit
sampl
hrvposit
sampl
covposit
sampl
race
sex
age
categori
year
allergi
travel
resid
hispan
selfidentif
describ
use
univari
multivari
regress
bestfit
model
identifi
use
akaik
inform
criterion
similarli
logist
regress
use
identifi
factor
associ
virusposit
sampl
ie
posit
vs
neg
consent
survey
swab
adult
april
juli
total
particip
femal
male
respond
either
transgend
gender
nonconform
nt
know
particip
selfidentifi
white
asian
blackafrican
american
american
indianalaska
nativ
nativ
hawaiianpacif
island
anoth
race
gave
respons
total
selfidentifi
hispan
age
distribut
follow
age
year
age
year
age
year
age
year
age
year
half
particip
receiv
influenza
vaccin
preced
year
total
sampl
test
posit
respiratori
viru
posit
sampl
hrv
posit
cov
posit
posit
human
metapneumoviru
influenza
viru
respiratori
syncyti
viru
parainfluenza
viru
tabl
virusposit
particip
identifi
throughout
studi
period
howev
rate
posit
lower
juli
april
may
june
coinfect
detect
across
particip
women
report
significantli
higher
total
symptom
score
men
p
anova
particip
age
year
year
year
report
significantli
lower
total
symptom
score
particip
age
year
p
tukey
test
addit
consumpt
cold
influenza
medicin
significantli
posit
associ
higher
total
symptom
score
p
anova
associ
held
analysi
restrict
test
posit
respiratori
viru
p
anova
among
particip
statist
signific
posit
associ
report
greater
tendenc
get
sick
total
selfreport
symptom
score
p
tukey
test
howev
signific
associ
report
greater
tendenc
get
sick
actual
detect
respiratori
viru
shed
p
analysi
test
posit
respiratori
viru
signal
intens
posit
associ
consumpt
cold
influenza
medicin
p
fisher
exact
test
associ
test
posit
receiv
influenza
vaccin
previou
year
recent
travel
locat
resid
among
particip
test
posit
qualifi
symptomat
depend
definit
use
tabl
rate
symptomat
differ
significantli
among
virusposit
virusneg
particip
p
comparison
analysi
fisher
exact
test
posit
particip
like
qualifi
symptomat
bestfit
logist
regress
model
support
associ
increas
likelihood
test
posit
respiratori
viru
infect
higher
total
symptom
score
p
hispan
p
similar
associ
found
likelihood
test
posit
hrv
higher
total
symptom
score
p
associ
increas
likelihood
test
posit
cov
among
test
posit
respiratori
viru
bestfit
model
reveal
statist
signific
neg
associ
genmark
esensor
rvp
signal
intens
age
categori
year
year
p
p
respect
rel
age
categori
year
posit
associ
season
allergi
p
hrv
signal
intens
regress
statist
signific
neg
associ
age
categori
year
p
rel
age
categori
year
emerg
regress
cov
signal
intens
reveal
complex
posit
associ
total
symptom
score
p
neg
associ
selfidentif
black
american
indianalaska
nativ
p
rel
white
age
categori
year
p
rel
age
categori
year
found
adult
particip
visit
new
york
citi
tourist
attract
late
spring
summer
test
posit
common
respiratori
viru
depend
definit
use
test
posit
qualifi
asymptomat
asymptomat
percentag
deriv
use
definit
respect
laxer
criteria
fell
within
broad
rang
found
prior
studi
definit
use
morestring
influenzalik
ill
symptom
criteria
yield
higher
asymptomat
percentag
twentysix
percent
particip
test
posit
report
total
symptom
score
contrast
particip
test
neg
common
respiratori
viru
qualifi
asymptomat
depend
definit
use
regardless
symptom
definit
particip
test
posit
ambulatori
take
time
visit
tourist
attract
howev
differ
suggest
peopl
experienc
influenzalik
ill
symptom
particular
fever
may
apt
stay
home
inde
fever
least
commonli
report
survey
symptom
among
test
posit
either
virus
hrv
alon
found
associ
esensor
signal
intens
particip
age
addit
signal
intens
posit
associ
selfreport
total
symptom
score
cov
previou
studi
well
manufactur
specif
indic
littl
associ
esensor
signal
intens
amount
viru
present
find
symptom
sever
shed
cov
posit
associ
warrant
investig
current
find
base
larg
divers
sampl
ambulatori
adult
provid
baselin
preval
respiratori
viru
shed
among
subpopul
northern
hemispher
summer
major
citi
tourist
abound
unclear
shed
among
approxim
adult
contribut
transmiss
pathogen
inde
nasopharyng
specimen
document
shed
contagi
particip
unclear
rhinoviru
coronaviru
preval
greater
abund
might
indic
virus
communic
possibl
higher
preval
link
immun
escap
innat
transmiss
sampl
scheme
introduc
bias
may
make
find
reflect
shed
across
entir
popul
specif
ill
individu
stay
home
feel
symptom
might
will
particip
studi
particip
selfreport
fever
wherea
thermomet
measur
might
provid
moredefinit
data
particip
report
symptom
last
hour
howev
respiratori
virus
rna
detect
week
follow
acut
ill
thu
fulli
determin
whether
asymptomat
posit
sampl
due
prior
ill
repres
incub
infect
truli
asymptomat
find
clearli
indic
substant
level
asymptomat
shed
exist
among
sampl
adult
ambulatori
popul
import
repeat
studi
winter
cold
influenza
season
determin
overal
infect
rate
infect
rate
viru
asymptomat
infect
rate
vari
summer
winter
find
present
use
complement
find
household
survey
improv
estim
viru
infect
incid
inform
model
simul
forecast
control
infect
due
pathogen
particular
medic
countermeasur
might
deploy
effect
true
scope
respiratori
viru
infect
incid
popul
better
understood
disclaim
view
opinion
andor
find
express
author
interpret
repres
offici
view
polici
depart
defens
us
govern
financi
support
work
support
defens
advanc
research
project
agenc
grant
potenti
conflict
interest
j
columbia
univers
disclos
equiti
sk
analyt
author
report
conflict
interest
author
submit
icmj
form
disclosur
potenti
conflict
interest
conflict
editor
consid
relev
content
manuscript
disclos
